Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Successful administration of neffy (epinephrine nasal spray) by patients and caregivers - Five human factor studies.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: May 07, 2026
Diverse Trial Designs, Populations, and Outcomes: A Systematic Literature Review of Trials for the Treatment of Hereditary Angioedema Attacks.
Journal: Advances in therapy
Published: April 09, 2026
Small molecules and their importance as therapeutic options in daily practice.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: April 01, 2026
Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema Prophylaxis.
Journal: Advances in therapy
Published: February 23, 2026
Donidalorsen for Long-Term Prophylaxis of Hereditary Angioedema Attacks: Results from the OASISplus Open-Label Extension Cohort at Year 1.
Journal: Journal of asthma and allergy
Published: January 21, 2026
Incorrect perceptions of first-line treatment of severe allergic reactions with over-the-counter products and how the epinephrine drug delivery system impacts behavior.
Journal: Allergy and asthma proceedings
Published: January 09, 2026
Donidalorsen for hereditary angioedema: Long-term results from a 4-year, phase 2, open-label extension study.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: December 17, 2025
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-S.
Journal: The journal of allergy and clinical immunology. Global
Published: December 01, 2025
Long-term prophylaxis in hereditary angioedema: Real-world treatment patterns and healthcare resource utilization.
Journal: The World Allergy Organization journal
Published: November 21, 2025
Open-label phase 1b/2 trial of navenibart, a long-acting plasma kallikrein inhibitor for hereditary angioedema.
Journal: The Journal of allergy and clinical immunology
Published: October 17, 2025
Multicenter questionnaire study investigating characteristics of adults with unexplained chronic cough versus explained chronic cough.
Journal: Allergy and asthma proceedings
Published: September 17, 2025
Last Updated: 09/26/2026